SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
IDOL JOHN D

(Last) (First) (Middle)
33 KINGSWAY

(Street)
LONDON X0 WC2B 6UF

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Michael Kors Holdings Ltd [ KORS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman & CEO
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary shares, no par value 06/02/2017 M 20,558 A (1) 1,696,506 D
Ordinary shares, no par value 06/02/2017 06/05/2017 F 10,388(2) D $33.05 1,686,118 D
Ordinary shares, no par value 06/02/2017 06/05/2017 F 2,804(2) D $33.05 1,683,314 D
Ordinary shares, no par value 06/03/2017 06/05/2017 F 4,382(2) D $34.49 1,678,932 D
Ordinary shares, no par value 95,000 I Held by the Idol Family Foundation
Ordinary shares, no par value 150,000 I Held by John D. Idol 2013 GRAT #1
Ordinary shares, no par value 150,000 I Held by John D. Idol 2013 GRAT #2
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance-based restricted share units $0 06/02/2017 M 20,558 (3) (3) Ordinary shares, no par value 20,558 $0 0 D
Restricted share units $0 (4) (5) Ordinary shares, no par value 15,924(6) 47,770 D
Employee share option (right to buy) $49.88 (7) 06/15/2023 Ordinary shares, no par value 14,503 14,503 D
Restricted share units $0 (7) (5) Ordinary shares, no par value 8,019 8,019 D
Employee share option (right to buy) $47.1 (4) 06/15/2022 Ordinary shares, no par value 107,604 107,604 D
Employee share option (right to buy) $94.45 (8) 06/02/2021 Ordinary shares, no par value 89,316 89,316 D
Employee share option (right to buy) $2.6316 (9) 02/18/2020 Ordinary shares, no par value 491,426 491,426 D
Employee share option (right to buy) $5 (9) 03/25/2021 Ordinary shares, no par value 456,000 456,000 D
Employee share option (right to buy) $20 (9) 12/14/2018 Ordinary shares, no par value 387,597 387,597 D
Employee share option (right to buy) $62.24 (9) 06/03/2020 Ordinary shares, no par value 84,219 84,219 D
Explanation of Responses:
1. Represents settlement of performance-based restricted share units ("PSRUs"). See footnote 3.
2. Represents shares withheld by the Company to cover tax withholding obligations upon vesting.
3. Represents PRSUs granted to the reporting person on June 2, 2014. The PSRUs vested on June 2, 2017 upon achievement of a pre-established cumulative net earnings goal for the applicable period resulting in the reporting person earning 86.3% of the ordinary shares originally subject to the award.
4. Granted on June 15, 2015 pursuant to the Michael Kors Holdings Limited Amended and Restated Omnibus Incentive Plan (the "Incentive Plan"). These securities vest 25% each year on June 15, 2016, 2017, 2018, and 2019, respectively, subject to grantee's continued employment with the Company through the vesting date.
5. The RSUs do not expire.
6. Settlement of this award will be satisfied through the issuance of one ordinary share for each vested RSU.
7. Granted on June 15, 2016 pursuant to the Incentive Plan. These securities vest 25% each year on June 15, 2017, 2018, 2019, and 2020, respectively, subject to grantee's continued employment with the Company through the vesting date.
8. Granted on June 2, 2014 pursuant to the Incentive Plan. 75% of these share options are immediately exercisable. The remaining unvested share options will vest on June 2, 2018, subject to grantee's continued employment with the Company through the vesting date.
9. Immediately exercisable.
/s/ Krista A. McDonough, as Attorney-in-Fact for John D. Idol 06/06/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.